Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia.
Family satisfaction following the death of a loved one in an inner city MICU.
A novel peptide derived from Haematococcus pluvialis residue balanced lipid metabolism through NHR-49/PPAR? and AAK-2/AMPK pathways in Caenorhabditis elegans.
Complement levels in patients with hepatic dysfunction.
See All 14 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Complement levels in patients with hepatic dysfunction.
Ellison RT, Horsburgh CR, Curd J. Complement levels in patients with hepatic dysfunction. Dig Dis Sci. 1990 Feb; 35(2):231-5.
View in:
PubMed
subject areas
Complement System Proteins
Female
Humans
Liver
Liver Diseases
Male
Prothrombin Time
Reference Values
Retrospective Studies
authors with profiles
Richard T Ellison III MD